Thye Dirk - Insider Non-Derivative Transactions at Quince Therapeutics, Inc. (QNCX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 30, 2024, Thye Dirk's relationship to Quince Therapeutics, Inc. (QNCX) is Director,Officer (CEO AND CHIEF MEDICAL OFFICER), and currently has 843,941 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other QNCX insiders.
Data Source: SEC.
Thye Dirk - Insider Non-Derivative Transactions of QNCX Common Stock
Thye Dirk - Insider Non-Derivative Transactions at QNCX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 31, 2024 | P -- (Common Stock) | 77000 | 0.7 | 843941 |
| Aug 30, 2024 | P -- (Common Stock) | 77500 | 0.69 | 766941 |
| Jan 17, 2024 | M -- (Common Stock) | 90531 | 0.55 | 539442 |
| Jan 17, 2024 | M -- (Common Stock) | 149999 | 0.94 | 689441 |
| Aug 11, 2023 | P -- (Common Stock) | 88000 | 1.26 | 448911 |
| Aug 9, 2023 | P -- (Common Stock) | 80000 | 1.24 | 360911 |